News

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute Informationen zu zwei Neuzugängen im wachsenden Anwendungsportfolio von QIAcuity, seiner Plattform zur Durchführung

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important expansion initiatives for its QuantiFERON franchise, building on its status as the gold standard for detection of

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute Details zur Erweiterung seines QuantiFERON-Portfolios bekannt. Basierend auf dem Status von QuantiFERON als Goldstandard zur

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present virtually at the 40^th Annual J.P. Morgan Healthcare Conference, which takes place January 10 – January

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11^th, at 10:30

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 40^th Annual

Premier, Inc. (NASDAQ: PINC) today announced that members of its management team will participate in the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11, 2022. The conference is a

Novocure (NASDAQ: NVCR) announced today it will participate in the 40^th Annual J.P. Morgan Virtual Healthcare Conference on January 10 through January 13, 2022. William Doyle, Novocure’s Executive

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the Company has completed the acquisition of CenterPointe Behavioral Health System, the largest dedicated behavioral healthcare

Respiratory therapists, who are essential to treating COVID-19 patients, top the list of most in-demand temporary allied healthcare professionals, according to a new survey by AMN Healthcare, the

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma today announced positive findings in the completed phase-IIIb DIAMOND trial of Veltassa^® in heart failure patients with

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has completed the acquisition of the real estate for three currently non-operational facilities, including one adult hospital

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211219005059/en/

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Fairview Health Services, one of Minnesota’s leading health systems. Through this partnership